International Journal of Cardiology: Heart & Vasculature (Dec 2022)

Association between right ventricular dysfunction and in-hospital mortality in surges of SARS-CoV-2 infection attributed to the Alpha, Delta, and Omicron variants

  • Alaa Mabrouk Salem Omar,
  • Nolberto Hernandez,
  • Diana Maria Ronderos Botero,
  • Angel Delacruz,
  • Sai Doppalapudi,
  • Vikram Itare,
  • Dongmin Shin,
  • Jaydeep Mahasamudram,
  • Neelanjana Pandey,
  • Nishant Allena,
  • Karan Sud,
  • Sridhar Chilimuri,
  • Jonathan N Bella

Journal volume & issue
Vol. 43
p. 101150

Abstract

Read online

Background: Right ventricular (RV) dysfunction in acute COVID-19 was reported to be associated with poor prognosis. We studied the association between parameters of RV dysfunction and in-hospital mortality during the surges caused by different SARS-CoV-2 variants. Methods: In a retrospective single-center study, we enrolled 648 consecutive patients hospitalized with COVID-19 [66 (10 %) hospitalized during the alpha variant surge, 433 (67 %) during the delta variant surge, and 149 (23 %), during the omicron variant surge]. Patients were reported from a hospital with an underreported population of mostly African American and Hispanic patients. Patients were followed for a median of 11 days during which in-hospital death occurred in 155 (24 %) patients [Alpha wave: 25 (38 %), Delta Wave: 112 (26 %), Omicron wave: 18 (12 %), p < 0.001]. Results: RV dysfunction occurred in 210 patients (alpha: 32 %, 26 %, delta: 29 %, and omicron: 49 %, p < 0.001) and was associated with higher mortality across waves, however, independently predicted in-hospital mortality in the Alpha (HR = 5.1, 95 % CI: 2.06–12.5) and Delta surges (HR = 1.6, 95 % CI: 1.11–2.44), but not in the Omicron surge. When only patients with RV dysfunction were compared, the mortality risk was found to decrease significantly from the Alpha (HR = 13.6, 95 % CI: 3.31–56.3) to the delta (HR = 1.93, 95 % CI: 1.25–2.96) and to the Omicron waves (HR = 11, 95 % CI: 0.6–20.8). Conclusions: RV dysfunction continues to occur in all strains of the SARS-CoV-2 virus, however, the mortality risk decreased from wave to wave likely due to evolution of better therapeutics, increase rate of vaccination, or viral mutations resulting in decrease virulence.Registration number of clinical studies: BronxCare Hospital center institutional review board under the number 05 13 21 04.

Keywords